

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of skin barrier (GO:0061436) | 9.15985110 |
| 2 | regulation of water loss via skin (GO:0033561) | 8.48166354 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 8.30791232 |
| 4 | peptide cross-linking (GO:0018149) | 7.43898633 |
| 5 | * intermediate filament organization (GO:0045109) | 7.31084484 |
| 6 | keratinocyte differentiation (GO:0030216) | 7.10843787 |
| 7 | * epidermis development (GO:0008544) | 6.15532281 |
| 8 | surfactant homeostasis (GO:0043129) | 5.86732636 |
| 9 | multicellular organismal water homeostasis (GO:0050891) | 5.79152503 |
| 10 | epidermal cell differentiation (GO:0009913) | 5.64125548 |
| 11 | negative regulation of keratinocyte proliferation (GO:0010839) | 5.39437061 |
| 12 | gap junction assembly (GO:0016264) | 5.02998698 |
| 13 | skin morphogenesis (GO:0043589) | 4.97947739 |
| 14 | keratinocyte development (GO:0003334) | 4.90547627 |
| 15 | chemical homeostasis within a tissue (GO:0048875) | 4.87092902 |
| 16 | water homeostasis (GO:0030104) | 4.81594719 |
| 17 | polarized epithelial cell differentiation (GO:0030859) | 4.67319060 |
| 18 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 4.67163974 |
| 19 | detection of bacterium (GO:0016045) | 4.51970034 |
| 20 | * intermediate filament cytoskeleton organization (GO:0045104) | 4.50280177 |
| 21 | cell adhesion mediated by integrin (GO:0033627) | 4.44577367 |
| 22 | * intermediate filament-based process (GO:0045103) | 4.33259742 |
| 23 | positive regulation of keratinocyte differentiation (GO:0045618) | 4.27660879 |
| 24 | ectoderm development (GO:0007398) | 4.17291569 |
| 25 | regulation of ruffle assembly (GO:1900027) | 4.11391451 |
| 26 | negative regulation of cell fate specification (GO:0009996) | 4.04691177 |
| 27 | regulation of phospholipase A2 activity (GO:0032429) | 4.01764625 |
| 28 | virion attachment to host cell (GO:0019062) | 4.01675435 |
| 29 | adhesion of symbiont to host cell (GO:0044650) | 4.01675435 |
| 30 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 4.00839429 |
| 31 | protein localization to endosome (GO:0036010) | 3.91900662 |
| 32 | regulation of chemokine secretion (GO:0090196) | 3.91814165 |
| 33 | keratinocyte proliferation (GO:0043616) | 3.90817410 |
| 34 | detection of other organism (GO:0098543) | 3.83479200 |
| 35 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.76595041 |
| 36 | endodermal cell differentiation (GO:0035987) | 3.71522345 |
| 37 | mesodermal cell differentiation (GO:0048333) | 3.71324887 |
| 38 | negative regulation of epidermis development (GO:0045683) | 3.67840420 |
| 39 | negative regulation of chondrocyte differentiation (GO:0032331) | 3.65646912 |
| 40 | sphingoid metabolic process (GO:0046519) | 3.64420887 |
| 41 | hypotonic response (GO:0006971) | 3.60801775 |
| 42 | cell junction assembly (GO:0034329) | 3.59841472 |
| 43 | phospholipid scrambling (GO:0017121) | 3.58910732 |
| 44 | interferon-gamma secretion (GO:0072643) | 3.51327728 |
| 45 | hair follicle morphogenesis (GO:0031069) | 3.46134327 |
| 46 | negative regulation of cell fate commitment (GO:0010454) | 3.44900384 |
| 47 | eyelid development in camera-type eye (GO:0061029) | 3.43431477 |
| 48 | cell junction organization (GO:0034330) | 3.41212058 |
| 49 | cell-substrate junction assembly (GO:0007044) | 3.39575355 |
| 50 | L-serine transport (GO:0015825) | 3.38563324 |
| 51 | cell-substrate adherens junction assembly (GO:0007045) | 3.37842178 |
| 52 | focal adhesion assembly (GO:0048041) | 3.37842178 |
| 53 | * regulation of hair follicle development (GO:0051797) | 3.37001435 |
| 54 | lymph vessel development (GO:0001945) | 3.33369522 |
| 55 | fatty acid elongation (GO:0030497) | 3.28596865 |
| 56 | atrioventricular valve morphogenesis (GO:0003181) | 3.28447577 |
| 57 | regulation of natural killer cell differentiation (GO:0032823) | 3.28077437 |
| 58 | non-canonical Wnt signaling pathway (GO:0035567) | 3.27017500 |
| 59 | diol metabolic process (GO:0034311) | 3.25112028 |
| 60 | morphogenesis of embryonic epithelium (GO:0016331) | 3.25077415 |
| 61 | adhesion of symbiont to host (GO:0044406) | 3.20872569 |
| 62 | skin development (GO:0043588) | 3.19154756 |
| 63 | regulation of glomerular filtration (GO:0003093) | 3.18866771 |
| 64 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.17602459 |
| 65 | molting cycle process (GO:0022404) | 3.15413021 |
| 66 | hair cycle process (GO:0022405) | 3.15413021 |
| 67 | gland morphogenesis (GO:0022612) | 3.15065850 |
| 68 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 3.14718340 |
| 69 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.14169987 |
| 70 | regulation of somitogenesis (GO:0014807) | 3.13096606 |
| 71 | establishment of planar polarity (GO:0001736) | 3.13041330 |
| 72 | establishment of tissue polarity (GO:0007164) | 3.13041330 |
| 73 | * epithelium development (GO:0060429) | 3.11956466 |
| 74 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.10322535 |
| 75 | response to phenylpropanoid (GO:0080184) | 3.08196162 |
| 76 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 3.06629388 |
| 77 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.03120284 |
| 78 | regulation of keratinocyte proliferation (GO:0010837) | 3.02668453 |
| 79 | renal filtration (GO:0097205) | 2.99105549 |
| 80 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.97974958 |
| 81 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.96299105 |
| 82 | regulation of cardioblast proliferation (GO:0003264) | 2.96299105 |
| 83 | sphingosine metabolic process (GO:0006670) | 2.94366693 |
| 84 | membrane tubulation (GO:0097320) | 2.94148820 |
| 85 | negative regulation of stress fiber assembly (GO:0051497) | 2.93152997 |
| 86 | hair follicle development (GO:0001942) | 2.88861769 |
| 87 | serine transport (GO:0032329) | 2.88813654 |
| 88 | adherens junction assembly (GO:0034333) | 2.88118055 |
| 89 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.84769561 |
| 90 | cardiac right ventricle morphogenesis (GO:0003215) | 2.82630943 |
| 91 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.81492148 |
| 92 | adherens junction organization (GO:0034332) | 2.79290621 |
| 93 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.78419982 |
| 94 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.77689121 |
| 95 | intestinal epithelial cell development (GO:0060576) | 2.77365391 |
| 96 | positive regulation of protein export from nucleus (GO:0046827) | 2.76416339 |
| 97 | regulation of cardioblast differentiation (GO:0051890) | 2.75480088 |
| 98 | ephrin receptor signaling pathway (GO:0048013) | 2.74699868 |
| 99 | renal system development (GO:0072001) | 2.71668927 |
| 100 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.70278182 |
| 101 | regulation of transforming growth factor beta production (GO:0071634) | 2.69832990 |
| 102 | mammary gland epithelial cell proliferation (GO:0033598) | 2.69584498 |
| 103 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.69167164 |
| 104 | * regulation of hair cycle (GO:0042634) | 2.68496168 |
| 105 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.68413914 |
| 106 | regulation of branching involved in prostate gland morphogenesis (GO:0060687) | 2.68272183 |
| 107 | renal absorption (GO:0070293) | 2.68231045 |
| 108 | negative regulation of interferon-gamma production (GO:0032689) | 2.66178647 |
| 109 | positive regulation of actin filament depolymerization (GO:0030836) | 2.65476333 |
| 110 | * positive regulation of epidermis development (GO:0045684) | 2.62952995 |
| 111 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.62798147 |
| 112 | regulation of keratinocyte differentiation (GO:0045616) | 2.60944573 |
| 113 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.60720093 |
| 114 | * regulation of epidermis development (GO:0045682) | 2.60553802 |
| 115 | cell communication involved in cardiac conduction (GO:0086065) | 2.59563312 |
| 116 | endosome organization (GO:0007032) | 2.58801675 |
| 117 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.58472126 |
| 118 | response to UV-B (GO:0010224) | 2.57609971 |
| 119 | lateral sprouting from an epithelium (GO:0060601) | 2.57013444 |
| 120 | positive regulation of cholesterol efflux (GO:0010875) | 2.56829606 |
| 121 | renal system process involved in regulation of blood volume (GO:0001977) | 2.54851661 |
| 122 | negative regulation of kidney development (GO:0090185) | 2.53407593 |
| 123 | wound healing (GO:0042060) | 2.51724433 |
| 124 | epithelial cell-cell adhesion (GO:0090136) | 2.51445214 |
| 125 | activation of Rac GTPase activity (GO:0032863) | 2.51373581 |
| 126 | odontogenesis (GO:0042476) | 2.51256402 |
| 127 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.50719213 |
| 128 | embryonic camera-type eye development (GO:0031076) | 2.49595917 |
| 129 | regulation of epidermal cell differentiation (GO:0045604) | 2.49465576 |
| 130 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.48695550 |
| 131 | extracellular matrix disassembly (GO:0022617) | 2.47902783 |
| 132 | cellular copper ion homeostasis (GO:0006878) | 2.47001590 |
| 133 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.45777706 |
| 134 | negative regulation of cartilage development (GO:0061037) | 2.45486109 |
| 135 | negative regulation of interleukin-2 production (GO:0032703) | 2.44440196 |
| 136 | negative regulation of stem cell proliferation (GO:2000647) | 2.44319035 |
| 137 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.43481311 |
| 138 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.42033142 |
| 139 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.41591455 |
| 140 | negative regulation of lipase activity (GO:0060192) | 2.41504362 |
| 141 | epithelial cell proliferation (GO:0050673) | 2.40580491 |
| 142 | desmosome organization (GO:0002934) | 14.0411766 |
| 143 | molting cycle (GO:0042303) | 13.6082521 |
| 144 | hair cycle (GO:0042633) | 13.6082521 |
| 145 | * keratinization (GO:0031424) | 11.2992377 |
| 146 | hemidesmosome assembly (GO:0031581) | 10.2334471 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.83631601 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.30915820 |
| 3 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.63989576 |
| 4 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 2.51573495 |
| 5 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.25783235 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.25725406 |
| 7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.09081723 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.08855297 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 15.1618248 |
| 10 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.92806626 |
| 11 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.92806626 |
| 12 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.90498737 |
| 13 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.60668414 |
| 14 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40836362 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.37921952 |
| 16 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36469490 |
| 17 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.36215468 |
| 18 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.35296082 |
| 19 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.34348687 |
| 20 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.28349919 |
| 21 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.27882478 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27656643 |
| 23 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26279094 |
| 24 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25810806 |
| 25 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25208771 |
| 26 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.24176679 |
| 27 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23832624 |
| 28 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.23822616 |
| 29 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.20833626 |
| 30 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19203137 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.18243055 |
| 32 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.17191244 |
| 33 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16481749 |
| 34 | CJUN_26792858_Chip-Seq_BT549_Human | 1.16195627 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.16184903 |
| 36 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16136517 |
| 37 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15280503 |
| 38 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.15220407 |
| 39 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12882349 |
| 40 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.11983540 |
| 41 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11926330 |
| 42 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.10088845 |
| 43 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09273931 |
| 44 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09066282 |
| 45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07523321 |
| 46 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05549433 |
| 47 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04978856 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.04824412 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.02710350 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00830898 |
| 51 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00637931 |
| 52 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.00570071 |
| 53 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.99616160 |
| 54 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.99378120 |
| 55 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.99378120 |
| 56 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.98751976 |
| 57 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98688621 |
| 58 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.98205863 |
| 59 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.98175406 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96794394 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.96703322 |
| 62 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95723100 |
| 63 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95352823 |
| 64 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93599410 |
| 65 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92677057 |
| 66 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.90543752 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89933252 |
| 68 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.89923275 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88478425 |
| 70 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.88436260 |
| 71 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.88108321 |
| 72 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88104284 |
| 73 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87792720 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87491012 |
| 75 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87397032 |
| 76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86505478 |
| 77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.85743888 |
| 78 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.85683530 |
| 79 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.85205855 |
| 80 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.83758290 |
| 81 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83700517 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.83192127 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82045425 |
| 84 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.81663164 |
| 85 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.81081541 |
| 86 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.80904480 |
| 87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.80870716 |
| 88 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.80066477 |
| 89 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.79262184 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.78978029 |
| 91 | TP53_16413492_ChIP-PET_HCT116_Human | 0.78943240 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.77940607 |
| 93 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77187853 |
| 94 | KDM2B_26808549_Chip-Seq_K562_Human | 0.76801857 |
| 95 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.75065094 |
| 96 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.74593114 |
| 97 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.74509015 |
| 98 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.74220525 |
| 99 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.74215651 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.74201170 |
| 101 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.74201170 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.73700455 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.72885230 |
| 104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72816710 |
| 105 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.72479651 |
| 106 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.71586181 |
| 107 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.71247608 |
| 108 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.71220870 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.70828000 |
| 110 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.70083231 |
| 111 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.69679982 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.68908308 |
| 113 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.67806059 |
| 114 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.67700011 |
| 115 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.67609950 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.67091773 |
| 117 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.63335438 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.63254024 |
| 119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.63056555 |
| 120 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.62706284 |
| 121 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.62319539 |
| 122 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.61850739 |
| 123 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.61549041 |
| 124 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.61164110 |
| 125 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.61135135 |
| 126 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.61104678 |
| 127 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.60935840 |
| 128 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.60799340 |
| 129 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.58314251 |
| 130 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.56806678 |
| 131 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.54663620 |
| 132 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.54128652 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.52825203 |
| 134 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.52367370 |
| 135 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.52314849 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.51334512 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002796_impaired_skin_barrier | 6.66508752 |
| 2 | * MP0000579_abnormal_nail_morphology | 5.47227989 |
| 3 | MP0010234_abnormal_vibrissa_follicle | 4.55228620 |
| 4 | MP0002254_reproductive_system_inflammat | 4.52824267 |
| 5 | MP0005275_abnormal_skin_tensile | 4.49686409 |
| 6 | MP0005501_abnormal_skin_physiology | 4.14233800 |
| 7 | MP0003941_abnormal_skin_development | 3.64005761 |
| 8 | * MP0002098_abnormal_vibrissa_morphology | 3.60009676 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 3.48409762 |
| 10 | MP0001216_abnormal_epidermal_layer | 3.43132508 |
| 11 | MP0002060_abnormal_skin_morphology | 3.30585129 |
| 12 | MP0000647_abnormal_sebaceous_gland | 3.24083911 |
| 13 | MP0000383_abnormal_hair_follicle | 3.19570332 |
| 14 | MP0000467_abnormal_esophagus_morphology | 3.05315398 |
| 15 | MP0003453_abnormal_keratinocyte_physiol | 2.99292474 |
| 16 | MP0010678_abnormal_skin_adnexa | 2.99003875 |
| 17 | * MP0000377_abnormal_hair_follicle | 2.70577723 |
| 18 | MP0010771_integument_phenotype | 2.67742808 |
| 19 | MP0001346_abnormal_lacrimal_gland | 2.56086849 |
| 20 | * MP0000762_abnormal_tongue_morphology | 2.42995686 |
| 21 | * MP0004381_abnormal_hair_follicle | 2.23874087 |
| 22 | MP0003566_abnormal_cell_adhesion | 2.09102556 |
| 23 | MP0004947_skin_inflammation | 2.07873993 |
| 24 | MP0005451_abnormal_body_composition | 1.98997886 |
| 25 | * MP0000427_abnormal_hair_cycle | 1.97484781 |
| 26 | MP0009053_abnormal_anal_canal | 1.89363136 |
| 27 | MP0001243_abnormal_dermal_layer | 1.88022253 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.76699613 |
| 29 | MP0000566_synostosis | 1.74545209 |
| 30 | MP0002234_abnormal_pharynx_morphology | 1.68599073 |
| 31 | MP0009931_abnormal_skin_appearance | 1.54392900 |
| 32 | MP0002009_preneoplasia | 1.54265114 |
| 33 | MP0008260_abnormal_autophagy | 1.52053605 |
| 34 | * MP0000367_abnormal_coat/_hair | 1.50810508 |
| 35 | MP0001191_abnormal_skin_condition | 1.47239985 |
| 36 | MP0008789_abnormal_olfactory_epithelium | 1.47096819 |
| 37 | MP0000516_abnormal_urinary_system | 1.46774523 |
| 38 | MP0005367_renal/urinary_system_phenotyp | 1.46774523 |
| 39 | MP0002877_abnormal_melanocyte_morpholog | 1.32902032 |
| 40 | MP0001851_eye_inflammation | 1.31567144 |
| 41 | MP0001849_ear_inflammation | 1.27980616 |
| 42 | MP0003315_abnormal_perineum_morphology | 1.23741379 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.15606076 |
| 44 | MP0005360_urolithiasis | 1.13972608 |
| 45 | MP0005257_abnormal_intraocular_pressure | 1.09108537 |
| 46 | MP0005409_darkened_coat_color | 1.06503304 |
| 47 | MP0000537_abnormal_urethra_morphology | 1.06008787 |
| 48 | MP0002249_abnormal_larynx_morphology | 1.04837506 |
| 49 | MP0001340_abnormal_eyelid_morphology | 1.03228641 |
| 50 | MP0004264_abnormal_extraembryonic_tissu | 0.98839006 |
| 51 | MP0005499_abnormal_olfactory_system | 0.96970565 |
| 52 | MP0005394_taste/olfaction_phenotype | 0.96970565 |
| 53 | MP0002282_abnormal_trachea_morphology | 0.96048206 |
| 54 | MP0000678_abnormal_parathyroid_gland | 0.93789219 |
| 55 | MP0004272_abnormal_basement_membrane | 0.93282525 |
| 56 | MP0005023_abnormal_wound_healing | 0.88191898 |
| 57 | MP0000627_abnormal_mammary_gland | 0.83510880 |
| 58 | MP0002233_abnormal_nose_morphology | 0.80907596 |
| 59 | MP0000858_altered_metastatic_potential | 0.80686488 |
| 60 | MP0005076_abnormal_cell_differentiation | 0.74507528 |
| 61 | * MP0003755_abnormal_palate_morphology | 0.73797906 |
| 62 | MP0002166_altered_tumor_susceptibility | 0.71328781 |
| 63 | MP0000685_abnormal_immune_system | 0.70311578 |
| 64 | MP0002006_tumorigenesis | 0.69828916 |
| 65 | MP0004858_abnormal_nervous_system | 0.69334160 |
| 66 | MP0000013_abnormal_adipose_tissue | 0.67745514 |
| 67 | MP0010352_gastrointestinal_tract_polyps | 0.66790753 |
| 68 | MP0000538_abnormal_urinary_bladder | 0.63578124 |
| 69 | MP0003763_abnormal_thymus_physiology | 0.63345613 |
| 70 | MP0000003_abnormal_adipose_tissue | 0.62991539 |
| 71 | MP0003091_abnormal_cell_migration | 0.62664987 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.61927126 |
| 73 | MP0003045_fibrosis | 0.61917410 |
| 74 | MP0009250_abnormal_appendicular_skeleto | 0.61250406 |
| 75 | MP0000613_abnormal_salivary_gland | 0.60149700 |
| 76 | MP0004019_abnormal_vitamin_homeostasis | 0.59175544 |
| 77 | MP0003828_pulmonary_edema | 0.55209357 |
| 78 | MP0003385_abnormal_body_wall | 0.54479098 |
| 79 | MP0005197_abnormal_uvea_morphology | 0.53941137 |
| 80 | MP0001299_abnormal_eye_distance/ | 0.53909740 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 0.53669745 |
| 82 | MP0009780_abnormal_chondrocyte_physiolo | 0.53340308 |
| 83 | MP0009379_abnormal_foot_pigmentation | 0.53326122 |
| 84 | MP0000470_abnormal_stomach_morphology | 0.53087534 |
| 85 | MP0005193_abnormal_anterior_eye | 0.52310648 |
| 86 | MP0001542_abnormal_bone_strength | 0.50764570 |
| 87 | MP0003011_delayed_dark_adaptation | 0.50397472 |
| 88 | MP0005508_abnormal_skeleton_morphology | 0.49272011 |
| 89 | MP0002111_abnormal_tail_morphology | 0.49176743 |
| 90 | MP0001661_extended_life_span | 0.49077320 |
| 91 | MP0003806_abnormal_nucleotide_metabolis | 0.48163968 |
| 92 | MP0003329_amyloid_beta_deposits | 0.47520403 |
| 93 | MP0002089_abnormal_postnatal_growth/wei | 0.47056512 |
| 94 | MP0000049_abnormal_middle_ear | 0.47039657 |
| 95 | MP0002177_abnormal_outer_ear | 0.46910745 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.46745446 |
| 97 | MP0001784_abnormal_fluid_regulation | 0.46344993 |
| 98 | MP0005375_adipose_tissue_phenotype | 0.43525116 |
| 99 | MP0005248_abnormal_Harderian_gland | 0.43247441 |
| 100 | MP0009840_abnormal_foam_cell | 0.42506855 |
| 101 | MP0005621_abnormal_cell_physiology | 0.42209800 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.42176696 |
| 103 | MP0004197_abnormal_fetal_growth/weight/ | 0.41944469 |
| 104 | MP0003300_gastrointestinal_ulcer | 0.41794658 |
| 105 | MP0003950_abnormal_plasma_membrane | 0.40997956 |
| 106 | MP0002697_abnormal_eye_size | 0.38693654 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.38392997 |
| 108 | MP0004782_abnormal_surfactant_physiolog | 0.38385202 |
| 109 | MP0000750_abnormal_muscle_regeneration | 0.37906935 |
| 110 | MP0000733_abnormal_muscle_development | 0.37703128 |
| 111 | MP0003724_increased_susceptibility_to | 0.37181609 |
| 112 | MP0003786_premature_aging | 0.36729415 |
| 113 | MP0008438_abnormal_cutaneous_collagen | 0.36443317 |
| 114 | MP0006138_congestive_heart_failure | 0.35615338 |
| 115 | MP0000432_abnormal_head_morphology | 0.34710464 |
| 116 | MP0002896_abnormal_bone_mineralization | 0.33869225 |
| 117 | MP0001853_heart_inflammation | 0.33599096 |
| 118 | MP0003448_altered_tumor_morphology | 0.33006358 |
| 119 | MP0000462_abnormal_digestive_system | 0.32411328 |
| 120 | MP0005330_cardiomyopathy | 0.32312651 |
| 121 | MP0005164_abnormal_response_to | 0.31712987 |
| 122 | MP0005623_abnormal_meninges_morphology | 0.29420489 |
| 123 | MP0010368_abnormal_lymphatic_system | 0.29178936 |
| 124 | MP0003936_abnormal_reproductive_system | 0.28757805 |
| 125 | MP0009384_cardiac_valve_regurgitation | 0.28514002 |
| 126 | MP0004885_abnormal_endolymph | 0.27422235 |
| 127 | MP0000534_abnormal_ureter_morphology | 0.25772747 |
| 128 | MP0003942_abnormal_urinary_system | 0.25536590 |
| 129 | MP0005390_skeleton_phenotype | 0.25141222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypotrichosis (HP:0001006) | 7.82569936 |
| 2 | Woolly hair (HP:0002224) | 7.47205082 |
| 3 | Milia (HP:0001056) | 7.38734518 |
| 4 | Fragile nails (HP:0001808) | 6.85870760 |
| 5 | Right ventricular cardiomyopathy (HP:0011663) | 6.83646981 |
| 6 | * Plantar hyperkeratosis (HP:0007556) | 6.67258194 |
| 7 | * Abnormality of nail color (HP:0100643) | 6.55036980 |
| 8 | Onycholysis (HP:0001806) | 6.01157346 |
| 9 | * Palmoplantar hyperkeratosis (HP:0000972) | 5.91824380 |
| 10 | Thick nail (HP:0001805) | 5.73065743 |
| 11 | Pili torti (HP:0003777) | 5.62951342 |
| 12 | * Palmar hyperkeratosis (HP:0010765) | 5.54697710 |
| 13 | Lip pit (HP:0100267) | 5.49180198 |
| 14 | Increased IgE level (HP:0003212) | 5.38139109 |
| 15 | Parakeratosis (HP:0001036) | 5.13669579 |
| 16 | * Nail dystrophy (HP:0008404) | 5.01536047 |
| 17 | Atrophic scars (HP:0001075) | 4.75576936 |
| 18 | Alopecia of scalp (HP:0002293) | 4.41210537 |
| 19 | * Abnormal blistering of the skin (HP:0008066) | 4.12068330 |
| 20 | Erythema (HP:0010783) | 4.05231752 |
| 21 | Sparse eyelashes (HP:0000653) | 3.88361656 |
| 22 | Selective tooth agenesis (HP:0001592) | 3.79373762 |
| 23 | Abnormal hair laboratory examination (HP:0003328) | 3.77369682 |
| 24 | * Natal tooth (HP:0000695) | 3.70012786 |
| 25 | Follicular hyperkeratosis (HP:0007502) | 3.67180616 |
| 26 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.59041620 |
| 27 | Ventricular tachycardia (HP:0004756) | 3.51878901 |
| 28 | Ridged nail (HP:0001807) | 3.51409059 |
| 29 | Hypoplastic labia majora (HP:0000059) | 3.32843935 |
| 30 | Aplasia cutis congenita (HP:0001057) | 3.17046469 |
| 31 | Fragile skin (HP:0001030) | 3.12696579 |
| 32 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.07165803 |
| 33 | * Advanced eruption of teeth (HP:0006288) | 3.06806418 |
| 34 | Erythroderma (HP:0001019) | 3.03838770 |
| 35 | Abnormality of the labia majora (HP:0012881) | 3.03041166 |
| 36 | Brittle hair (HP:0002299) | 2.98527720 |
| 37 | Abnormality of placental membranes (HP:0011409) | 2.95370624 |
| 38 | Amniotic constriction ring (HP:0009775) | 2.95370624 |
| 39 | Acanthosis nigricans (HP:0000956) | 2.85763890 |
| 40 | Abnormality of the gastric mucosa (HP:0004295) | 2.84259961 |
| 41 | Hypoplasia of dental enamel (HP:0006297) | 2.79241429 |
| 42 | Fatigable weakness (HP:0003473) | 2.78704643 |
| 43 | Abnormality of the neuromuscular junction (HP:0003398) | 2.78704643 |
| 44 | Down-sloping shoulders (HP:0200021) | 2.73219387 |
| 45 | * Palmoplantar keratoderma (HP:0000982) | 2.63830663 |
| 46 | Hypohidrosis (HP:0000966) | 2.63279555 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 2.61408985 |
| 48 | Corneal erosion (HP:0200020) | 2.56488857 |
| 49 | Curly hair (HP:0002212) | 2.55134556 |
| 50 | Ectropion (HP:0000656) | 2.46705899 |
| 51 | Pterygium (HP:0001059) | 2.40734839 |
| 52 | Abnormality of hair growth rate (HP:0011363) | 2.39623540 |
| 53 | Slow-growing hair (HP:0002217) | 2.39623540 |
| 54 | Pruritus (HP:0000989) | 2.37625178 |
| 55 | Skin pits (HP:0100276) | 2.36142313 |
| 56 | Conjunctival hamartoma (HP:0100780) | 2.34410117 |
| 57 | Oral leukoplakia (HP:0002745) | 2.32038123 |
| 58 | Blepharitis (HP:0000498) | 2.31435034 |
| 59 | Premature rupture of membranes (HP:0001788) | 2.31059692 |
| 60 | Congenital, generalized hypertrichosis (HP:0004540) | 2.27373611 |
| 61 | Increased connective tissue (HP:0009025) | 2.25067301 |
| 62 | Ventricular fibrillation (HP:0001663) | 2.21393960 |
| 63 | Esophageal atresia (HP:0002032) | 2.20933420 |
| 64 | * Anonychia (HP:0001798) | 2.14986088 |
| 65 | Upper limb muscle weakness (HP:0003484) | 2.09209416 |
| 66 | Labial hypoplasia (HP:0000066) | 2.05512038 |
| 67 | Multifactorial inheritance (HP:0001426) | 2.03305570 |
| 68 | Absent hair (HP:0002298) | 2.02458879 |
| 69 | * Sparse scalp hair (HP:0002209) | 1.96893954 |
| 70 | * Hyperhidrosis (HP:0000975) | 1.96305819 |
| 71 | Amelogenesis imperfecta (HP:0000705) | 1.94813670 |
| 72 | Dehydration (HP:0001944) | 1.94072889 |
| 73 | Breast hypoplasia (HP:0003187) | 1.93833825 |
| 74 | Oligodontia (HP:0000677) | 1.93650958 |
| 75 | Gangrene (HP:0100758) | 1.93280767 |
| 76 | Cheilitis (HP:0100825) | 1.92756867 |
| 77 | Hypoplastic female external genitalia (HP:0012815) | 1.91604652 |
| 78 | Distal lower limb amyotrophy (HP:0008944) | 1.90878540 |
| 79 | Abnormality of the parietal bone (HP:0002696) | 1.89666903 |
| 80 | Neonatal death (HP:0003811) | 1.88397818 |
| 81 | Squamous cell carcinoma (HP:0002860) | 1.87248704 |
| 82 | Nasolacrimal duct obstruction (HP:0000579) | 1.86497957 |
| 83 | Septate vagina (HP:0001153) | 1.86104507 |
| 84 | Xerostomia (HP:0000217) | 1.84605941 |
| 85 | Split foot (HP:0001839) | 1.83901719 |
| 86 | Popliteal pterygium (HP:0009756) | 1.83164772 |
| 87 | * Laryngomalacia (HP:0001601) | 1.82271369 |
| 88 | Hypoplasia of the uterus (HP:0000013) | 1.80048266 |
| 89 | Achilles tendon contracture (HP:0001771) | 1.79911915 |
| 90 | Absent eyelashes (HP:0000561) | 1.76884654 |
| 91 | Hypergammaglobulinemia (HP:0010702) | 1.74638612 |
| 92 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.74152399 |
| 93 | Neonatal onset (HP:0003623) | 1.73959044 |
| 94 | Aplasia involving bones of the extremities (HP:0009825) | 1.73826458 |
| 95 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.73826458 |
| 96 | Aplasia of the phalanges of the hand (HP:0009802) | 1.73826458 |
| 97 | Skin ulcer (HP:0200042) | 1.72921628 |
| 98 | Trismus (HP:0000211) | 1.71447291 |
| 99 | Type 1 muscle fiber predominance (HP:0003803) | 1.71388563 |
| 100 | * Abnormality of the fingernails (HP:0001231) | 1.69722776 |
| 101 | * Corneal dystrophy (HP:0001131) | 1.67632370 |
| 102 | Abnormality of the Achilles tendon (HP:0005109) | 1.65695180 |
| 103 | Concave nail (HP:0001598) | 1.65120582 |
| 104 | Abnormality of the salivary glands (HP:0010286) | 1.62806322 |
| 105 | * Carious teeth (HP:0000670) | 1.61854660 |
| 106 | Abnormality of oral frenula (HP:0000190) | 1.61109611 |
| 107 | Hypodontia (HP:0000668) | 1.59833078 |
| 108 | Neurofibrillary tangles (HP:0002185) | 1.59364670 |
| 109 | Abnormality of permanent molar morphology (HP:0011071) | 1.58350413 |
| 110 | Abnormality of the dental root (HP:0006486) | 1.58350413 |
| 111 | Taurodontia (HP:0000679) | 1.58350413 |
| 112 | Ankyloglossia (HP:0010296) | 1.57819459 |
| 113 | Autoamputation (HP:0001218) | 1.56666420 |
| 114 | Hyporeflexia of lower limbs (HP:0002600) | 1.55601923 |
| 115 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.53659294 |
| 116 | Broad face (HP:0000283) | 1.53063006 |
| 117 | Scapular winging (HP:0003691) | 1.53037321 |
| 118 | Ureteral stenosis (HP:0000071) | 1.52839101 |
| 119 | Abnormality of secondary sexual hair (HP:0009888) | 1.51171678 |
| 120 | Abnormality of the axillary hair (HP:0100134) | 1.51171678 |
| 121 | Abnormal sex determination (HP:0012244) | 1.50694321 |
| 122 | Sex reversal (HP:0012245) | 1.50694321 |
| 123 | Abnormal hemoglobin (HP:0011902) | 1.49738414 |
| 124 | Axonal loss (HP:0003447) | 1.49482261 |
| 125 | Peritonitis (HP:0002586) | 1.49267504 |
| 126 | Duplicated collecting system (HP:0000081) | 1.48650803 |
| 127 | Obstructive sleep apnea (HP:0002870) | 1.48474109 |
| 128 | Eczematoid dermatitis (HP:0000976) | 1.48196210 |
| 129 | Short nail (HP:0001799) | 1.47117665 |
| 130 | Osteolytic defects of the hand bones (HP:0009699) | 1.46561934 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.46561934 |
| 132 | Pustule (HP:0200039) | 1.46298704 |
| 133 | Abnormality of molar (HP:0011077) | 1.45050859 |
| 134 | Abnormality of molar morphology (HP:0011070) | 1.45050859 |
| 135 | Abnormality of the lacrimal duct (HP:0011481) | 1.44469497 |
| 136 | Ureteral duplication (HP:0000073) | 1.43536611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHB2 | 5.39530048 |
| 2 | MST4 | 4.87226452 |
| 3 | MAPKAPK3 | 4.19651921 |
| 4 | ARAF | 3.28139071 |
| 5 | FER | 3.18454609 |
| 6 | NTRK1 | 3.00783176 |
| 7 | LATS1 | 2.95956680 |
| 8 | MAP3K3 | 2.63895291 |
| 9 | STK24 | 2.56556059 |
| 10 | EPHA2 | 2.35123792 |
| 11 | EEF2K | 2.33694555 |
| 12 | RPS6KB2 | 2.33031698 |
| 13 | FRK | 2.27993245 |
| 14 | MST1R | 2.19348820 |
| 15 | FLT3 | 2.17626959 |
| 16 | TRPM7 | 2.09717041 |
| 17 | ERN1 | 2.06306676 |
| 18 | CDK3 | 2.03710574 |
| 19 | PIM2 | 1.82753845 |
| 20 | MAP3K2 | 1.75903735 |
| 21 | ERBB3 | 1.56518398 |
| 22 | MAP3K10 | 1.55094628 |
| 23 | PTK6 | 1.54184175 |
| 24 | LMTK2 | 1.53396109 |
| 25 | MAPK15 | 1.52386686 |
| 26 | RIPK1 | 1.51718617 |
| 27 | STK10 | 1.46828561 |
| 28 | EPHA3 | 1.45845655 |
| 29 | NME1 | 1.45007160 |
| 30 | LRRK2 | 1.41485224 |
| 31 | MAP3K6 | 1.40115972 |
| 32 | PAK4 | 1.39765991 |
| 33 | DYRK1B | 1.37417523 |
| 34 | FGFR4 | 1.36165556 |
| 35 | MAPKAPK5 | 1.32952800 |
| 36 | EPHB1 | 1.31142661 |
| 37 | MAP3K14 | 1.27602666 |
| 38 | NME2 | 1.26256250 |
| 39 | EPHA4 | 1.25524445 |
| 40 | TAOK1 | 1.20998712 |
| 41 | TRIB3 | 1.14516201 |
| 42 | SMG1 | 1.13455126 |
| 43 | KSR2 | 1.11739153 |
| 44 | TGFBR2 | 1.11661632 |
| 45 | GRK1 | 1.10853486 |
| 46 | TYK2 | 1.09916644 |
| 47 | MET | 1.09358445 |
| 48 | STK38L | 1.07483305 |
| 49 | PIK3CG | 1.07424617 |
| 50 | BRAF | 1.06710203 |
| 51 | PTK2 | 1.00117333 |
| 52 | PBK | 0.97967684 |
| 53 | MAPKAPK2 | 0.97510451 |
| 54 | PRPF4B | 0.95578397 |
| 55 | BCR | 0.94925305 |
| 56 | MOS | 0.94339247 |
| 57 | STK38 | 0.92790218 |
| 58 | MAP2K2 | 0.89811128 |
| 59 | CDK12 | 0.88372944 |
| 60 | MAP3K13 | 0.87357581 |
| 61 | NEK9 | 0.87061052 |
| 62 | MAP3K12 | 0.86299135 |
| 63 | RAF1 | 0.84236931 |
| 64 | TESK1 | 0.80561812 |
| 65 | MAP3K7 | 0.78428146 |
| 66 | MAP3K9 | 0.77387002 |
| 67 | MAP2K6 | 0.76601970 |
| 68 | TNK2 | 0.70469727 |
| 69 | DYRK3 | 0.70158214 |
| 70 | LATS2 | 0.67586694 |
| 71 | TTN | 0.66709983 |
| 72 | MAP3K1 | 0.66288105 |
| 73 | BMX | 0.65927098 |
| 74 | HIPK2 | 0.65879355 |
| 75 | CDK6 | 0.64297949 |
| 76 | STK3 | 0.63907799 |
| 77 | JAK3 | 0.63518017 |
| 78 | ROCK2 | 0.62217299 |
| 79 | PRKD2 | 0.61399552 |
| 80 | ERBB2 | 0.61356594 |
| 81 | IRAK3 | 0.60661992 |
| 82 | PRKCE | 0.60607836 |
| 83 | CHUK | 0.57653554 |
| 84 | DDR2 | 0.57176371 |
| 85 | TGFBR1 | 0.56668561 |
| 86 | PRKCI | 0.54988417 |
| 87 | ERBB4 | 0.53710436 |
| 88 | MTOR | 0.53700195 |
| 89 | BMPR1B | 0.53591892 |
| 90 | NUAK1 | 0.52743380 |
| 91 | MAP2K1 | 0.52409731 |
| 92 | ABL2 | 0.52385935 |
| 93 | CSF1R | 0.51793528 |
| 94 | LIMK1 | 0.50575757 |
| 95 | IKBKE | 0.49508793 |
| 96 | JAK1 | 0.49214787 |
| 97 | CDC42BPA | 0.48248173 |
| 98 | MAP3K8 | 0.48139038 |
| 99 | RPS6KA4 | 0.47886683 |
| 100 | PRKD1 | 0.47239358 |
| 101 | ILK | 0.45431818 |
| 102 | JAK2 | 0.44682060 |
| 103 | NEK6 | 0.43557199 |
| 104 | CSNK1D | 0.42958219 |
| 105 | NTRK2 | 0.41015396 |
| 106 | ROCK1 | 0.40172443 |
| 107 | PAK2 | 0.39905272 |
| 108 | TBK1 | 0.39512590 |
| 109 | BTK | 0.39120008 |
| 110 | PAK3 | 0.37811739 |
| 111 | PDGFRA | 0.37427155 |
| 112 | ICK | 0.37419280 |
| 113 | SIK1 | 0.37413363 |
| 114 | FGFR2 | 0.36501287 |
| 115 | FGFR3 | 0.35884024 |
| 116 | SIK3 | 0.35289327 |
| 117 | FGFR1 | 0.34464555 |
| 118 | CLK1 | 0.34153022 |
| 119 | MATK | 0.34058564 |
| 120 | KSR1 | 0.33864926 |
| 121 | RPS6KL1 | 0.33063956 |
| 122 | RPS6KC1 | 0.33063956 |
| 123 | RET | 0.32179770 |
| 124 | AURKA | 0.31949213 |
| 125 | NLK | 0.31944464 |
| 126 | * RPS6KA1 | 0.31290800 |
| 127 | IKBKB | 0.30983839 |
| 128 | SRC | 0.30540570 |
| 129 | MAP3K11 | 0.29938741 |
| 130 | PKN2 | 0.29658331 |
| 131 | ADRBK1 | 0.29330380 |
| 132 | MAPK3 | 0.28569986 |
| 133 | HCK | 0.28008734 |
| 134 | PDGFRB | 0.28003406 |
| 135 | ITK | 0.27881452 |
| 136 | GSK3A | 0.27873432 |
| 137 | RPS6KA2 | 0.27779698 |
| 138 | FGR | 0.27679293 |
| 139 | CDK7 | 0.27511007 |
| 140 | RPS6KB1 | 0.26823668 |
| 141 | NEK1 | 0.19242891 |
| 142 | RPS6KA6 | 0.18264082 |
| 143 | SGK223 | 0.17259244 |
| 144 | SGK494 | 0.17259244 |
| 145 | SGK3 | 0.16829490 |
| 146 | INSR | 0.16190615 |
| 147 | EIF2AK2 | 0.15940821 |
| 148 | PRKG2 | 0.15844217 |
| 149 | TSSK6 | 0.15824943 |
| 150 | PRKCD | 0.14815999 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.06175832 |
| 2 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.95578404 |
| 3 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.75746826 |
| 4 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.69192353 |
| 5 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.51711200 |
| 6 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.35612714 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.20374427 |
| 8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.20189737 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12839402 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.10416505 |
| 11 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.04073256 |
| 12 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.01384397 |
| 13 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.91536110 |
| 14 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.85663777 |
| 15 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.85244285 |
| 16 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.83458384 |
| 17 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83449610 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.78867888 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.74640341 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.69370921 |
| 21 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.58870547 |
| 22 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.58155028 |
| 23 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.57826384 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.54751966 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.52147425 |
| 26 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.46797793 |
| 27 | Axon guidance_Homo sapiens_hsa04360 | 1.44081711 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43672087 |
| 29 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.41725441 |
| 30 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40380478 |
| 31 | Melanogenesis_Homo sapiens_hsa04916 | 1.39241793 |
| 32 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.38276753 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.34414647 |
| 34 | Tight junction_Homo sapiens_hsa04530 | 1.31830864 |
| 35 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.27452540 |
| 36 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.23585654 |
| 37 | Ribosome_Homo sapiens_hsa03010 | 1.23028563 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 1.20731401 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.17401528 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.16182205 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 1.16149426 |
| 42 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.14201495 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.13124030 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12807724 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.10602072 |
| 46 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.10457610 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09576013 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.09057726 |
| 49 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.08178475 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.08055325 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 1.06274852 |
| 52 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.05611143 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.05533395 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05352795 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 1.03550746 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.00265665 |
| 57 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99290192 |
| 58 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.98886488 |
| 59 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.98221165 |
| 60 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.96588476 |
| 61 | Salmonella infection_Homo sapiens_hsa05132 | 0.94703952 |
| 62 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93383037 |
| 63 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.92510069 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.87283181 |
| 65 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.86934761 |
| 66 | Endocytosis_Homo sapiens_hsa04144 | 0.86649667 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.86258593 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.84767850 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.83697574 |
| 70 | Focal adhesion_Homo sapiens_hsa04510 | 0.82282033 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82125489 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82079871 |
| 73 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.81904412 |
| 74 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81338177 |
| 75 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.80251920 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78385586 |
| 77 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74552824 |
| 78 | Phototransduction_Homo sapiens_hsa04744 | 0.73989934 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73409855 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.72507365 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.72482304 |
| 82 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.70377905 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.69627328 |
| 84 | Pathways in cancer_Homo sapiens_hsa05200 | 0.69463317 |
| 85 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68992925 |
| 86 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68662185 |
| 87 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67828792 |
| 88 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67570338 |
| 89 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.67087774 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | 0.66744283 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66353896 |
| 92 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64309335 |
| 93 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63980422 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61148503 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.61123090 |
| 96 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60262565 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.60209260 |
| 98 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59920439 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.59482018 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58212482 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.58112537 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.57804401 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57448809 |
| 104 | Renin secretion_Homo sapiens_hsa04924 | 0.56248620 |
| 105 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55833882 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.55611964 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55399434 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.54459935 |
| 109 | Long-term depression_Homo sapiens_hsa04730 | 0.53596051 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53137619 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52945725 |
| 112 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.52129565 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50786824 |
| 114 | Glioma_Homo sapiens_hsa05214 | 0.49776705 |
| 115 | Platelet activation_Homo sapiens_hsa04611 | 0.49697259 |
| 116 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48930773 |
| 117 | Olfactory transduction_Homo sapiens_hsa04740 | 0.48718845 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.48367298 |
| 119 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.48313067 |
| 120 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47776199 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.47509183 |
| 122 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46760960 |
| 123 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46235306 |
| 124 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46096126 |
| 125 | Tuberculosis_Homo sapiens_hsa05152 | 0.45723433 |
| 126 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44947167 |
| 127 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.44598651 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44357153 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.44239712 |
| 130 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.43464079 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.43320313 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.42512087 |
| 133 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42391878 |
| 134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.42170349 |
| 135 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41922047 |
| 136 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.41802548 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.41726105 |
| 138 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40028938 |
| 139 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.39577474 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39477296 |
| 141 | Melanoma_Homo sapiens_hsa05218 | 0.39112001 |
| 142 | Prostate cancer_Homo sapiens_hsa05215 | 0.38660191 |
| 143 | Insulin resistance_Homo sapiens_hsa04931 | 0.36992196 |
| 144 | Malaria_Homo sapiens_hsa05144 | 0.36904481 |
| 145 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36646751 |
| 146 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33147681 |
| 147 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.32793557 |
| 148 | Influenza A_Homo sapiens_hsa05164 | 0.32785690 |
| 149 | Gap junction_Homo sapiens_hsa04540 | 0.32650231 |
| 150 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.32647529 |

